GROWTH-HORMONE RELEASING ACTIVITY BY INTRANASAL ADMINISTRATION OF A SYNTHETIC HEXAPEPTIDE (HEXARELIN)

被引:27
作者
LARON, Z
FRENKEL, J
GILAD, I
KLINGER, B
LUBIN, E
WUTHRICH, P
BOUTIGNON, F
LENGERTS, V
DEGHENGHI, R
机构
[1] TEL AVIV UNIV,FELSENSTEIN MED RES CTR,IL-69978 TEL AVIV,ISRAEL
[2] TEL AVIV UNIV,THYROID LAB,IL-69978 TEL AVIV,ISRAEL
[3] TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL
[4] EUROPEPTIDES,ARGENTEUIL,FRANCE
关键词
D O I
10.1111/j.1365-2265.1994.tb02589.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Hexarelin is a new synthetic growth hormone releasing peptide. We have tested the efficacy of intranasal (i.n.) administration of hexarelin to stimulate plasma GH and have compared this to the intravenous (i.v.) administration of the peptide. PATIENTS Ten children with familial short stature (FSS) aged 5.5-15.5 years and two known GH deficient patients aged 24 and 28 years without GH treatment. METHODS All 12 subjects were submitted to i.v. (1 mu g/kg) and i.n. (20 mu g/kg) hexarelin tests with a one-week interval between tests. Blood samples for GH, TSH, fT4 and T3 were obtained at 0, 15, 30, 60, 90 and 120 minutes. The hormone determinations were made by standard radioimmunoassays (RIA). RESULTS Both the i.n. and i.v. administration of hexarelin Induced a large GH response, the mean (+/- SD) being 72.2 +/- 35.5 mU/I for the i.n. test and 79.6 +/- 53.0 mU/I for the i.v. test. The peak GH in the i.v. test occurred at 15-30 minutes and in the i.n. test between 30 and 60 minutes. The GH deficient patients showed no GH response in either test. Plasma TSH decreased in the FSS children from a mean (+/- SD) of 1.0 +/- 0.26 to 0.64 +/- 0.2 mU/I (P < 0.005) during the i.n. test and from 1.0 +/- 0.3 to 0.7 +/- 0.3 mU/I (P < 0.05) during the i.v. test. In the isolated GH deficient patient, plasma TSH decreased from 1.06 +/- 0.38 mU/I to 0.86 +/- 0.17 during the i.v. test and from 1.60 +/- 0.01 to 1.11 +/- 0.06 mU/I during the i.n. test. There were no significant changes in plasma fT4 or T3 in any of the tests. CONCLUSIONS The synthetic hexapeptide hexarelin is a potent pituitary GH stimulator when administered intranasally. The GH response was similar to that observed after intravenous hexarelin. Simultaneously, there was a significant decrease in plasma TSH but the concentrations remained in the normal range. These findings appear to be of theoretical and practical relevance to the investigation and management of short children.
引用
收藏
页码:539 / 541
页数:3
相关论文
共 11 条
[1]   GROWTH-HORMONE (GH)-RELEASING PEPTIDE STIMULATES GH RELEASE IN NORMAL MEN AND ACTS SYNERGISTICALLY WITH GH-RELEASING HORMONE [J].
BOWERS, CY ;
REYNOLDS, GA ;
DURHAM, D ;
BARRERA, CM ;
PEZZOLI, SS ;
THORNER, MO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (04) :975-982
[2]   ON THE INVITRO AND INVIVO ACTIVITY OF A NEW SYNTHETIC HEXAPEPTIDE THAT ACTS ON THE PITUITARY TO SPECIFICALLY RELEASE GROWTH-HORMONE [J].
BOWERS, CY ;
MOMANY, FA ;
REYNOLDS, GA ;
HONG, A .
ENDOCRINOLOGY, 1984, 114 (05) :1537-1545
[3]  
DEGHENGHI R, 1994, IN PRESS LIFE SCI
[4]  
GHIGO E, 1993, J ENDOCRINOL INV S10, V16, P34
[5]  
JOSEFSBERG Z, 1987, ISRAEL J MED SCI, V23, P837
[6]   GROWTH-HORMONE RELEASING HORMONE (GH-RH, GRF) - AN IMPORTANT NEW CLINICAL TOOL [J].
LARON, Z ;
BAUMAN, B .
EUROPEAN JOURNAL OF PEDIATRICS, 1986, 145 (1-2) :6-9
[7]   INTRAVENOUS ADMINISTRATION OF RECOMBINANT IGF-I LOWERS SERUM GHRH AND TSH [J].
LARON, Z ;
KLINGER, B ;
SILBERGELD, A ;
LEWIN, R ;
ERSTER, B ;
GILAD, I .
ACTA ENDOCRINOLOGICA, 1990, 123 (03) :378-382
[8]  
LARON Z, 1966, ISRAEL J MED SCI, V2, P115
[9]   GROWTH HORMONE-RELEASING ACTIVITY OF GROWTH HORMONE-RELEASING PEPTIDE-1 (A SYNTHETIC HEPTAPEPTIDE) IN CHILDREN AND ADOLESCENTS [J].
LARON, Z ;
BOWERS, CY ;
HIRSCH, D ;
ALMONTE, AS ;
PELZ, M ;
KERET, R ;
GILAD, I .
ACTA ENDOCRINOLOGICA, 1993, 129 (05) :424-426
[10]   INFLUENCE OF SEX, AGE AND ADRENERGIC PATHWAYS ON THE GROWTH-HORMONE RESPONSE TO GHRP-6 [J].
PENALVA, A ;
POMBO, M ;
CARBALLO, A ;
BARREIRO, J ;
CASANUEVA, FF ;
DIEGUEZ, C .
CLINICAL ENDOCRINOLOGY, 1993, 38 (01) :87-91